Growth at a CAGR of 9.7% in the Immunoassay Market during the forecast period, 2018 to 2023| Key Players - ABBOTT LABORATORIES INC., HOLOGIC (GEN-PROBE), LUMINEX CORPORATION, QIAGEN, amongst others

Market Analysis:

North America to Dominate the Market
North America dominates the Global Immunoassays Market which is mainly driven by increasing incidence of chronic disease and use of immunoassays in oncology. Also the technological advancement in the immunoassay products are driving market growth.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16732
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Compared to conventional tests, immunoassays have been proven to provide highly accurate results even with very small samples. Immunoassays have a range of applications in pharmaceutical analysis such as diagnosis of disease, therapeutic drug monitoring, clinical pharmacokinetics and bioequivalence in drug discovery and pharmaceutical industries. Additionally, cost effectives and rapid analysis by the immunoassays and growth in the biotechnology and pharmaceutical sectors are also driving the growth of the Global Immunoassays Market. The limit of detection (LOD) for most of the immunoassays is limited primarily by the signal-to-noise ratio provided by the instrument that is used to detect antibody-antigen binding or by non-specific binding (NSB).

Request Discount on this report @ https://marketprognosis.com/discount-request/16732
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
Immunoassay Market is segmented by:
1. TECHNOLOGY: ENZYME IMMUNOASSAY, FLUORESCENCE IMMUNOASSAY, CHEMILUMINESCENCE IMMUNOASSAY, RADIOIMMUNOASSAY, NEPHELOMETRIC IMMUNOASSAY, OTHERS
2. THERAPEUTIC AREA: CARDIOLOGY, THYROID, AUTOIMMUNE DISEASE, ONCOLOGY, INFECTIOUS DISEASE, HEMATOLOGY, ALLERGY, OTHERS
3. END USER: HOSPITAL, CENTRALIZED LABORATORY, ACADEMIC INSTITUTION, PHARMA & BIOTECH FIRM, CONTRACT RESEARCH ORGANIZATION, OTHERS
4. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• September 2017: Meridian Life science Inc. launches TRUBlock Ultra which is an active immunoassay interference blocker created by HAMA, rheumatoid factor (RH) and heterophillic antibodies (HA).
• June 2017: Qiagen developed QFT-Plus which detects latent tuberculosis infection got FDA approval.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/16732
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.